Cubist Systematic Strategies LLC Sells 74,908 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Cubist Systematic Strategies LLC lessened its stake in Huron Consulting Group Inc. (NASDAQ:HURN) by 95.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,471 shares of the business services provider’s stock after selling 74,908 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Huron Consulting Group were worth $342,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Covestor Ltd raised its stake in Huron Consulting Group by 26,500.0% in the first quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock valued at $26,000 after buying an additional 265 shares during the period. Ashton Thomas Private Wealth LLC acquired a new stake in Huron Consulting Group during the 2nd quarter valued at $28,000. Daiwa Securities Group Inc. boosted its position in Huron Consulting Group by 800.0% during the first quarter. Daiwa Securities Group Inc. now owns 1,800 shares of the business services provider’s stock worth $174,000 after purchasing an additional 1,600 shares during the period. Dakota Wealth Management acquired a new position in shares of Huron Consulting Group in the second quarter valued at $219,000. Finally, PNC Financial Services Group Inc. raised its position in shares of Huron Consulting Group by 39.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,555 shares of the business services provider’s stock valued at $263,000 after purchasing an additional 724 shares during the period. 93.90% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts recently commented on HURN shares. Benchmark reaffirmed a “buy” rating and set a $140.00 target price on shares of Huron Consulting Group in a report on Wednesday, July 31st. Barrington Research reiterated an “outperform” rating and set a $137.00 target price on shares of Huron Consulting Group in a research note on Monday, September 9th. Finally, StockNews.com upgraded Huron Consulting Group from a “sell” rating to a “hold” rating in a research note on Saturday, August 3rd. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $131.75.

Huron Consulting Group Stock Up 1.2 %

Shares of HURN opened at $106.61 on Monday. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 0.99. Huron Consulting Group Inc. has a 12 month low of $84.26 and a 12 month high of $115.65. The firm’s 50 day moving average is $106.49 and its 200-day moving average is $99.46. The stock has a market capitalization of $1.92 billion, a PE ratio of 30.72 and a beta of 0.61.

Huron Consulting Group (NASDAQ:HURN) last posted its quarterly earnings data on Tuesday, July 30th. The business services provider reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.20. The firm had revenue of $371.70 million for the quarter, compared to analyst estimates of $374.33 million. Huron Consulting Group had a return on equity of 20.44% and a net margin of 5.46%. The company’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $1.38 EPS. Equities research analysts forecast that Huron Consulting Group Inc. will post 5.95 EPS for the current year.

Insider Transactions at Huron Consulting Group

In related news, CEO C. Mark Hussey sold 4,000 shares of Huron Consulting Group stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $103.13, for a total value of $412,520.00. Following the transaction, the chief executive officer now directly owns 81,081 shares of the company’s stock, valued at $8,361,883.53. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Hugh E. Sawyer III sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $104.09, for a total value of $312,270.00. Following the sale, the director now directly owns 23,802 shares of the company’s stock, valued at $2,477,550.18. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO C. Mark Hussey sold 4,000 shares of Huron Consulting Group stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $103.13, for a total value of $412,520.00. Following the completion of the transaction, the chief executive officer now owns 81,081 shares in the company, valued at approximately $8,361,883.53. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,168 shares of company stock valued at $1,170,515. Company insiders own 2.02% of the company’s stock.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.